Accueil/Actions/XOMAP

XOMAP

USD

XOMA Royalty Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

$25.600+0.000 (0.000%)

Prix en Temps Réel

Healthcare

Biotechnologie

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$25.600

Haut

$25.600

Bas

$25.600

Volume

0.00M

Fondamentaux de l'Entreprise

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.00M

Bourse

NGM

Devise

USD

Intervalle sur 52 Semaines

Bas $24.96Actuel $25.600Haut $26.51

Actualités Connexes

27 mai 2025 · 12:01

GlobeNewswire

XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million

EMERYVILLE, Calif. and LUND, Sweden, May 27, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ:XOMA), the biotech royalty aggregator, and BioInvent International AB ("BioInvent") (Nasdaq Stockholm: BINV), a

XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million

7 mai 2025 · 11:30

GlobeNewswire

XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference

EMERYVILLE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ:XOMA), the biotech royalty aggregator, announced today its Chief Executive Officer, Owen Hughes, and Chief Investment Officer, Brad